Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Rheumatology Reports

01.08.2010

Quality-of-Life Measurements Versus Disease Activity in Systemic Lupus Erythematosus

verfasst von: Adnan N. Kiani, Michelle Petri

Erschienen in: Current Rheumatology Reports | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE) is a chronic disease affecting the physical, social, and psychological well-being of patients. Different instruments have been developed to measure health-related quality of life, some of which are SLE-specific. Contributors to poor quality of life in patients with SLE include fatigue, fibromyalgia, depression, and cognitive dysfunction. Health-related quality of life is not strongly associated with disease activity or organ damage. The Medical Outcomes Survey Short Form 36 is the most common instrument used to measure quality of life in SLE.
Literatur
1.
Gladman DD, Urowitz MB, Ong A, et al.: Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 1996, 14:305–308.PubMed
2.
Ware JE Jr, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36). Conceptual framework and item selection. Med Care 1992, 30:473–483.CrossRefPubMed
3.
Alarcon G, McGwin G, Uribe A, et al.: Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 2004, 51:465–474.CrossRefPubMed
4.
Godaert G, Hartkamp A, Geenen R, et al.: Fatigue in daily life in patients with primary Sjogren’s syndrome and systemic lupus erythematosus. Ann N Y Acad Sci 2002, 966:320–326.CrossRefPubMed
5.
Bruce I, Mak V, Hallett D, et al.: Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 1999, 58:379–381.CrossRefPubMed
6.
Tench CM, McCurdie I, White PD, D’Cruz D: The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology 2000, 39:1249–1259.CrossRefPubMed
7.
Krupp L, LaRocca N, Muir J, Steinberg A: A study of fatigue in systemic lupus erythematosus. J Rheumatol 1990, 17:1450–1453.PubMed
8.
McKinley P, Ouellette S, Winkel G: The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. Arthritis Rheum 1995, 38:826–834.CrossRefPubMed
9.
Dobkin P, DaCosta D, Fortin P, et al.: Living with lupus: a prospective pan-Canadian study. J Rheumatol 2001, 28:2442–2448.PubMed
10.
Hanly JG, Fisk JD, McCurdy G, et al.: Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2005, 32:1459–1466.PubMed
11.
Iverson GL, Sawyer DC, McCracken LM, Kozora E: Assessing depression in systemic lupus erythematosus: determining reliable change. Lupus 2001, 10:266–271.CrossRefPubMed
12.
Gladman DD, Urowitz MB, Gough J, MacKinnon A: Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 1997, 24:2145–2148.PubMed
13.
Greco C, Rudy T, Manzi S: Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus. J Rheumatol 2004, 31:260–267.PubMed
14.
• Petri M, Naqibuddin M, Carson KA, et al.: Cognitive function in a systemic lupus erythematosus cohort. J Rheumatol 2008, 35:1776–1781. We showed marked cognitive dysfunction in newly diagnosed SLE patients. Cognitive dysfunction is an important contributor to poor quality of life among SLE patients.CrossRefPubMed
15.
Omdal R, Waterloo K, Koldingsnes W, et al.: Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects. J Rheumatol 2003, 30:283–287.PubMed
16.
Jump R, Robinson ME, Armstrong A, et al.: Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression and perceived social support. J Rheumatol 2005, 32:1699–1705.PubMed
17.
Daltroy LH, Robb-Nicholson C, Iversen MD, et al.: Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. Br J Rheumatol 1995, 34:1064–1069.CrossRefPubMed
18.
Tench CM, McCarthy J, McCurdie I, et al.: Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford) 2003, 42:1050–1054.CrossRef
19.
• Avina-Zubieta JA: Ad hoc committee on systemic lupus erythematosus response criteria for fatigue. Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum 2007, 57:1348–1357. This is a detailed review of different instruments used to measure fatigue in SLE patients.CrossRef
20.
Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicentre criteria committee. Arthritis Rheum 1990, 33:160–172.CrossRefPubMed
21.
Lawrence RC, Helmick CG, Arnett FC, et al.: Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778–799.CrossRefPubMed
22.
Wolfe F, Ross K, Anderson J, et al.: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19–28.CrossRefPubMed
23.
Middleton GD, McFarlin JE, Lipsky PE: The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994, 37:1181–1188.CrossRefPubMed
24.
Romano TJ: Fibromyalgia prevalence in patients with systemic lupus erythematosus. Arthritis Rheum 1995, 38:118.CrossRef
25.
Buskila D, Press J, Abu-Shakra M: Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol 2003, 25:25–28.CrossRefPubMed
26.
Da Costa D, Dobkin PL, Fitzcharles MA, et al.: Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. J Rheumatol 2000, 27:365–372.PubMed
27.
Schlenk EA, Erlen JA, Dunbar Jacob J, et al.: Health related quality of life in chronic disorders: a comparison across studies using the MOS SF36. Qual Life Res 1998, 7:57–65.CrossRefPubMed
28.
Abu-Shakra M, Mader R, Langevitz P, et al.: Quality of life in systemic lupus erythematosus: a controlled study. J Rheumatol 1999, 26:306–309.PubMed
29.
Ledingham J, Dohertz S, Dohertz M: Primary fibromyalgia syndrome—an outcome study. Br J Rheumatol 1993, 32:139–142.CrossRefPubMed
30.
Burckhardt CS, Clark SR, Bennett RM: Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993, 20:475–479.PubMed
31.
Wolfe F, Anderson J, Harkness D, et al.: Health status and disease severity in FM: results of a six-center longitudinal study. Arthritis Rheum 1997, 40:1571–1579.CrossRefPubMed
32.
Utset TO, Golden M, Petri M, et al.: Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren’s syndrome. J Rheumatol 1994, 21:2039–2045.PubMed
33.
Rinaldi S, Doria A, Ermani M, et al.: Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology 2004, 43:1580–1586.CrossRefPubMed
34.
Wilson I, Cleary P: Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995, 273:59–65.CrossRefPubMed
35.
Liang M, Rogers M, Larson M, et al.: The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1984, 27:13–19.CrossRefPubMed
36.
Carbotte RM, Denburg SD, Denburg JA: Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986, 174:357–364.CrossRefPubMed
37.
Hanly JG, Fisk JD, Sherwood G, et al.: Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992, 19:562–567.PubMed
38.
Hay EM, Black D, Huddy A, et al.: Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 1992, 35:411–416.CrossRefPubMed
39.
Leritz E, Brandt J, Petri M, et al.: “Subcortical” cognitive impairment in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 2000, 6:821–825.CrossRefPubMed
40.
Kirk A, Kertesz A, Polk MJ: Dementia with leukoencephalopathy in systemic lupus erythematosus. Can J Neurol Sci 1991, 18:344–348.PubMed
41.
Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA: The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 1997, 3:377–386.PubMed
42.
Denburg JA, Carbotte RA, Denburg SD: Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 1987, 37:464–467.PubMed
43.
Hanly JG, Behmann S, Denburg SD, et al.: The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus. Postgrad Med J 1989, 65:622–627.CrossRefPubMed
44.
Denburg SD, Carbotte RM, Denburg JA: Cognitive impairment in SLE: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 1987, 19:323–339.CrossRef
45.
Wang C, Mayo NE, Fortin PR: The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001, 28:525–532.PubMed
46.
Gordon C, Clarke A: Quality of life and economic evaluation in SLE clinical trials. Lupus 1999, 8:645–654.CrossRefPubMed
47.
Fortin PR, Abrahamowicz M, Neville C, et al.: Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998, 7:101–107.CrossRefPubMed
48.
Gilboe I, Kvien T, Husby G: Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol 1999, 26:1694-1700.PubMed
49.
Sutcliffe N, Clarke A, Levinton C, et al.: Associates of health status in patients with systemic lupus erythematosus. J Rheumatol 1999, 26:2352–2356.PubMed
50.
Benitha R, Mohammed T: Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2007, 26:24–29.CrossRefPubMed
51.
Stoll T, Gordon C, Seifert B, et al.: Consistency and validity of patient administered assessment of quality of life by the MOSF SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997, 24:1608–1614.PubMed
52.
Thumboo J, Fong K, Ng T, et al.: Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999, 26:97–102.PubMed
53.
Gladman DD, Urowitz MB, Ong A, et al.: A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 1996, 5:190–195.CrossRefPubMed
54.
Pincus T, Summey J, Soraci SJ, et al.: Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983, 26:1346–1353.CrossRefPubMed
55.
Bergner M, Bobbitt RA, Carter WB, et al.: The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981, 19:787–805.CrossRefPubMed
56.
EuroQoL—a new facility for the measurement of health-related quality of life. The EuroQoL Group. Health Policy 1990, 16:199–208.
57.
• McElhone K, Abbott J, Shelmerdine J, et al.: Development and validation of a disease-specific health-related quality of life measure, the LupusQoL, for adults with systemic lupus erythematosus. Arthritis Rheum 2007, 15:972–979. This article reviews a “lupus-specific” instrument, its development, and its validation.CrossRef
58.
Grootscholten C, Ligtenberg G, Derksen RH, et al.: Health-related quality of life in patients with systemic lupus erythematosus: development and validation of a lupus specific symptom checklist. Qual Life Res 2003, 12:635–644.CrossRefPubMed
59.
Leong KP, Kong KO, Thong BY, et al.: Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQoL). Rheumatology (Oxford) 2005, 44:1267–1276.CrossRef
60.
Wiginton KL: Illness representations: mapping the experience of lupus. Health Educ Behav 1999, 26:443–453.CrossRefPubMed
61.
Kong KO, Ho HJ, Howe HS, et al.: Cross-cultural adaptation of the Systemic Lupus Erythematosus Quality of Life Questionnaire into Chinese. Arthritis Rheum 2007, 57:980–985.CrossRefPubMed
62.
63.
Sutcliffe N, Clarke AE, Gordon C, et al.: The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology 1999, 38:1130–1137.CrossRefPubMed
64.
Fortin PR, Abrahamowickz M, Neville C, et al.: Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998, 7:101–107.CrossRefPubMed
65.
Khanna S, Pal H, Pandey RM, Handa R: The relationship between disease activity and quality of life in systemic lupus erythematosus. Rheumatology 2004, 43:1536–1540.CrossRefPubMed
66.
Wang H, Mayo N, Fortin P: The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol 2001, 28:525–532.PubMed
67.
Alarcon G, McGwin G Jr, Uribe A, et al.: Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self reported health-related quality of life early in the disease course. Arthritis Rheum 2004, 51:465–474.CrossRefPubMed
68.
Friedman A, Alarcon G, Mcgwin G, et al.: Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study. Arthritis Care Res 1999, 12:256–266.CrossRefPubMed
69.
Dorsey R, Andresen E, Moore T: Health-related quality of life and support group attendance for patients with systemic lupus erythematosus. J Clin Rheumatol 2004, 10:6–9.CrossRefPubMed
70.
Rinaldi S, Doria A, Salaffi F, et al.: Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology 2004, 43:1574–1579.CrossRefPubMed
71.
Juenger J, Schellberg D, Kraemer S, et al.: Health-related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002, 87:235–241.CrossRefPubMed
72.
Ragsdale D, Morrow J: Quality of life as a function of HIV classification. Nurs Res 1990, 39:355–359.CrossRefPubMed
73.
Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarrabia F: EuroQoL is a useful instrument for assessing the health related quality of life of the patients with systemic lupus erythematosus. Lupus 2005, 14:334–335.CrossRefPubMed
74.
Luo N, Chew LH, Fong KY, et al.: Validity and reliability of the EQ-5D self-report questionnaire in English-speaking Asian patients with rheumatic diseases in Singapore. Qual Life Res 2003, 12:87–92.CrossRefPubMed
75.
Luo N, Chew LH, Fong KY, et al.: Validity and reliability of the EQ-5D self-report questionnaire in Chinese-speaking patients with rheumatic diseases in Singapore. Ann Acad Med Singapore 2003, 32:685–690.PubMed
76.
Wolfe F: Health-status questionnaires. Rheum Dis Clin North Am 1995, 21:445–464.PubMed
77.
Hochberg MC, Sutton JD: Physical-disability and psychosocial dysfunction in systemic lupus erythematosus. J Rheumatol 1988, 15:959–964.PubMed
78.
Milligan SE, Hom DL, Ballou SP, et al.: An assessment of the health assessment questionnaire functional ability index among women with systemic lupus erythematosus. J Rheumatol 1993, 20:972–996.PubMed
79.
DeBruin AF, De Witte LP, Stevens F, et al.: Sickness Impact Profile: the state of the art of a generic functional status measure. Soc Sci Med 1992, 35:1003–1014.CrossRef
80.
Wysenbeek A, Leibovici L, Weinberger A, Guedj D: Fatigue in systemic lupus erythematosus. Prevalence and relation to disease expression. Br J Rheumatol 1993, 32:633–635.CrossRefPubMed
81.
Zonana-Nacach A, Roseman J, McGwin G Jr, et al.: Systemic lupus erythematosus in three ethnic groups VI Factors associated with fatigue within 5 years of criteria diagnosis. Lupus 2000, 9:101–109.CrossRefPubMed
82.
Da Costa D, Clarke A, Dobkin P, et al.: The relationship between health status, social support and satisfaction with medical care among patients with systemic lupus erythematosus. Int J Qual Health Care 1999, 11:201–207.CrossRefPubMed
83.
Bae S, Hashimoto H, Karlson E, et al.: Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol 2001, 28:1245–1250.PubMed
84.
Devins GM, Edworthy SM: Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus erythematosus. Lupus 2000, 9:534–541.CrossRefPubMed
85.
Stoll T, Kauer Y, Buchi S, et al.: Prediction of depression in systemic lupus erythematosus patients using SF-36 mental health scores. Rheumatology 2001, 40:695–698.CrossRefPubMed
86.
Thumboo J, Fong K, Chan S, et al.: A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol 2000, 27:1414–1420.PubMed
87.
Doninger N, Fink J, Utset T: Neuropsychologic functioning and health status in systemic lupus erythematosus. Does ethnicity matter? J Clin Rheumatol 2005, 11:250–256.CrossRefPubMed
88.
Regidor E, Barrio G, De la Fuente L, et al.: Association between educational level and health related quality of life in Spanish adults. J Epidemiol Community Health 1999, 53:75–82.CrossRefPubMed
89.
Ward M: Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthritis Rheum 2004, 51:616–624.CrossRefPubMed
90.
Hanly JG: Disease activity, cumulative damage and quality of life in systemic lupus erythematosus: results of a cross-sectional study. Lupus 1997, 6:243–247.CrossRefPubMed
91.
Dobkin P, Da Costa D, Dritsa M, et al.: Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res 1999, 12:402–410.CrossRef
92.
Jolly M, Utset TO: Can disease specific measures for systemic lupus erythematosus predict patients’ health related quality of life? Lupus 2004, 13:924–926.CrossRefPubMed
93.
Thumboo F, Fong KY, Ng T-P, et al.: Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999, 26:97–102.PubMed
94.
• Kuriya B, Gladman DD, Ibanez D, Urowitz MB: Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 2008, 59:181–185. This article shows FM to be an important contributor to poor quality of life in SLE patients, as measured by the SF-36.CrossRefPubMed
95.
Burckhardt CS, Archenholtz B, Bjelle A: Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: a Swedish version of the Quality of Life Scale (QOLS). Scand J Rheumatol 1992, 21:190–195.CrossRefPubMed
96.
Strand V, Aranow C, Cardiel MH, et al.: Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo. Lupus 2003, 12:677–686.CrossRefPubMed
97.
Nordmark G, Bengtsson C, Larsson A, et al.: Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity 2005, 38:531–540.CrossRefPubMed
98.
Petri M, Kim M, Kalunian K, et al.: Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005, 353:2550–2558.CrossRefPubMed
Metadaten
Titel
Quality-of-Life Measurements Versus Disease Activity in Systemic Lupus Erythematosus
verfasst von
Adnan N. Kiani
Michelle Petri
Publikationsdatum
01.08.2010
Verlag
Current Science Inc.
Erschienen in
Current Rheumatology Reports / Ausgabe 4/2010
Print ISSN: 1523-3774
Elektronische ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-010-0114-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Nierenkarzinom | Nachrichten

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 | NSCLC | Nachrichten

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Metformin rückt in den Hintergrund

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise